Rainer Lenhard
Directeur/Membre du Conseil chez ADVANZ PHARMA CORP. LIMITED
Postes actifs de Rainer Lenhard
Sociétés | Poste | Début | Fin |
---|---|---|---|
ADVANZ PHARMA CORP. LIMITED | Directeur/Membre du Conseil | - | - |
NC Advisory GmbH | Private Equity Investor | 01/06/2019 | - |
Historique de carrière de Rainer Lenhard
Anciens postes connus de Rainer Lenhard
Sociétés | Poste | Début | Fin |
---|---|---|---|
Goldman Sachs Bank Europe SE (Germany)
Goldman Sachs Bank Europe SE (Germany) Investment Banks/BrokersFinance Goldman Sachs Bank Europe SE (Germany) (GS Bank Europe-Germany) is the Germany-based broker-dealer subsidiary of Goldman Sachs (Cayman) Holding Co., which is owned by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. Headquartered in Frankfurt, GS Bank Europe-Germany was founded in 1990 and provides prime brokerage and securities underwriting services. | Directeur/Membre du Conseil | 01/01/2006 | 31/05/2019 |
Formation de Rainer Lenhard
Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
WHU-Otto Beisheim School of Management | Undergraduate Degree |
Statistiques
Internationale
Allemagne | 5 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 2 |
Private Equity Investor | 1 |
Doctorate Degree | 1 |
Sectorielle
Finance | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
NC Advisory GmbH | Finance |
Advanz Pharma Corp. Ltd.
Advanz Pharma Corp. Ltd. Pharmaceuticals: MajorHealth Technology ADVANZ PHARMA Corp. Ltd. is a pharmaceutical company engages in the provision of branded and unbranded products. The firm specializes in anti-Infectives and endocrinology therapy areas. It operates through the following segments: Advanz Pharma International; Advanz Pharma North America; and Corporate. The Advanz Pharma International segment include portfolio of branded and generic products that are sold to wholesalers, hospitals, and pharmacies. The Advanz Pharma North America segment comprises branded products and authorized generic contracts that focuses primarily on the U.S. pharmaceutical market. The Corporate segment represents the centralized costs. The company was founded by Mark L. Thompson on January 20, 2010 and is headquartered in St. Helier, the United Kingdom. | Health Technology |
Goldman Sachs Bank Europe SE (Germany)
Goldman Sachs Bank Europe SE (Germany) Investment Banks/BrokersFinance Goldman Sachs Bank Europe SE (Germany) (GS Bank Europe-Germany) is the Germany-based broker-dealer subsidiary of Goldman Sachs (Cayman) Holding Co., which is owned by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. Headquartered in Frankfurt, GS Bank Europe-Germany was founded in 1990 and provides prime brokerage and securities underwriting services. | Finance |
- Bourse
- Insiders
- Rainer Lenhard
- Expérience